Cargando…

Cyro-EM structure of human mGlus: leading therapeutic potential to neurological diseases

Detalles Bibliográficos
Autores principales:	Xiao, Huan, Sun, Qiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367988/ https://www.ncbi.nlm.nih.gov/pubmed/34400607 http://dx.doi.org/10.1038/s41392-021-00720-2

Ejemplares similares

Novel Cryo-EM structures of the D1 dopamine receptor unlock its therapeutic potential
por: Sibley, David R., et al.
Publicado: (2021)

A promising small molecule binding pocket in class B GPCRs: expanding potential for drug development
por: Xiao, Huan, et al.
Publicado: (2023)

Mutations in the Two-Component GluS-GluR Regulatory System Confer Resistance to β-Lactam Antibiotics in Burkholderia glumae
por: Marunga, Joan, et al.
Publicado: (2021)

Saliva biomarkers in neurological disorders: A “spitting image” of brain health?
por: Walton, Emma Louise
Publicado: (2018)

Structural basis of signaling of cannabinoids receptors: paving a way for rational drug design in controling mutiple neurological and immune diseases
por: Huang, Shenming, et al.
Publicado: (2020)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Mild Respiratory COVID-Induced Neuroinflammation Causes Neurological Deficits
por: Yang, Junlin, et al.
Publicado: (2022)

Microbial antibiotics take the lead in the fight against plant pathogens
por: Roca, Amalia, et al.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

Historia de la entrada de Cyro el Menor en el Asia, y de la retirada de los dies mil griegos que fueron con él
por: Xenofonte
Publicado: (1892)

Historia de la entrada de Cyro el Menor en el Asia : y de la retirada de los diez mil griegos que fueron con él
por: Xenofonte
Publicado: (1910)

Granulation of m(1)A-modified mRNAs protects their functionality through cellular stress
por: Jiang, Hao
Publicado: (2020)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

Cell perturbation in choroid plexus and cortex aiding COVID-19 neurological symptoms
por: Mao, Xiao-Yuan, et al.
Publicado: (2021)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

Stachel-mediated activation of adhesion G protein-coupled receptors: insights from cryo-EM studies
por: Liebscher, Ines, et al.
Publicado: (2022)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

Novel discovery in roles of structural variations and RWP-RK transcription factors in heat tolerance for pearl millet
por: Huang, Bingru, et al.
Publicado: (2023)

Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)

New insights into the neurological effects of COVID-19
por: Wood, Heather
Publicado: (2020)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Structural basis of PKM2 regulation
por: Yang, Weiwei
Publicado: (2015)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

EAN VIRTUAL 2020 — THE LARGEST NEUROLOGY CONFERENCE IN HISTORY
por: Fyfe, Ian
Publicado: (2020)

MXene-Graphene Composites: A Perspective on Biomedical Potentials
por: Mostafavi, Ebrahim, et al.
Publicado: (2022)

Highlight: Not Like a Textbook—Nuclear Genes in Blastocystis Use mRNA Polyadenylation for Stop Codons
por: Venton, Danielle
Publicado: (2014)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

Spinal cord concussion: studying the potential risks of repetitive injury
por: Fischer, Itzhak, et al.
Publicado: (2016)

Sequence capture by hybridization reveals elusive hydrocarbon degradation potential
por: von Netzer, Frederick
Publicado: (2017)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

Safety and efficacy of COVID-19 vaccines in people with neurological disorders
por: Wood, Heather
Publicado: (2021)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Make immunological peace not war: Potential applications of tolerogenic dendritic cells
por: Walton, Emma Louise
Publicado: (2017)

Structures of BRAF–MEK1–14-3-3 sheds light on drug discovery
por: Sun, Qiu, et al.
Publicado: (2019)

SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic
por: Ismail, Alaa M., et al.
Publicado: (2020)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kfdsagdrki7r1mljoh04clirhi